Még nem toboroz
Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease Undergoing PTCA
NCT07869602· Yonsei University· Forrás
Contact: Yongcheol Kim, MD.,PhD
Még nem toboroz
Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke
NCT07730840· 3. fázis· Asan Medical Center· Forrás
Contact: Hyun Goo Kang, MD, PhD
Toboroz
Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2)
NCT07741721· Chonnam National University Hospital· Forrás
Contact: Min Chul Kim, MD, PhD
Toboroz
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
NCT07733765· 3. fázis· Pfizer· Forrás
Még nem toboroz
Functional And STructural Assesment of the Heart by Artificial Intelligence-enabled Electrocardiogram for the Management of Atrial Fibrillation
NCT07486739· Seoul National University Hospital· Forrás
Contact: Jung Rae-Young
Fut, nem toboroz
Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above
NCT07481604· 2. fázis· Aribio Lab Co., Ltd.· Forrás
Toboroz
LEXURE for Post-Stroke Aphasia
NCT07570264· Nunaps Inc· Forrás
Contact: Hyun Goo Kang, MD, PhD
Toboroz
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
NCT07533006· 2. fázis· Eli Lilly and Company· Forrás
Contact: Jin Park (principal investigator)
Toboroz
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07363694· 2/3. fázis· Pfizer· Forrás
Toboroz
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
NCT07687706· 3. fázis· Hanyang University Guri Hospital· Forrás
Contact: Seong-Ho Koh, MD, PhD
Toboroz
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
NCT07128199· 3. fázis· Taiho Oncology, Inc.· Forrás
Contact: Taiho Oncology, Inc.
Toboroz
Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE)
NCT07009418· Samsung Medical Center· Forrás
Contact: Yisik Kim, MD, PhD
Toboroz
Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NCT06954714· Chonnam National University Hospital· Forrás
Contact: Yi Sik Kim, MD, PhD
Toboroz
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
NCT06824168· 2. fázis· Daiichi Sankyo· Forrás
Toboroz
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT07002164· Chonnam National University Hospital· Forrás
Contact: Youngkeun Ahn, Professor
Toboroz
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
NCT06757764· 4. fázis· Asan Medical Center· Forrás
Contact: Hyun Goo Kang, MD, PhD
Toboroz
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
NCT06962098· 2. fázis· Aptabio Therapeutics, Inc.· Forrás
Contact: Won Kim
Toboroz
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581· 2. fázis· Pfizer· Forrás
Toboroz
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
NCT06873945· 3. fázis· Pfizer· Forrás
Toboroz
Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial
NCT06724653· Chungnam National University Hospital· Forrás
Contact: Jiyeonn Lee
Toboroz
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
NCT06731478· 3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
NCT06578247· 3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866· 3. fázis· Amgen· Forrás
Fut, nem toboroz
A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
NCT06311721· 3. fázis· Amgen· Forrás
Toboroz
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
NCT06227754· Chonnam National University Hospital· Forrás
Contact: Yi Sik Kim, MD, PhD
Toboroz
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
NCT06246123· Eisai Korea Inc.· Forrás
Contact: Serena SoYoun Kwon
Fut, nem toboroz
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
NCT05995600· 4. fázis· Seoul National University Hospital· Forrás
Fut, nem toboroz
A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
NCT06256328· 2. fázis· Ono Pharmaceutical Co., Ltd.· Forrás
Toboroz
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
NCT06149286· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
NCT05730036· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
NCT06088121· Advanced Technology & Communications· Forrás
Contact: AT&C
Toboroz
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
NCT05723198· 3. fázis· Eli Lilly and Company· Forrás
Contact: Jin Park (principal investigator)
Toboroz
OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation
NCT05418556· 4. fázis· Asan Medical Center· Forrás
Contact: Yisik Kim, MD
Fut, nem toboroz
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
NCT05455320· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
NCT05144854· 3. fázis· Ono Pharmaceutical Co., Ltd.· Forrás
Fut, nem toboroz
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
NCT04725994· 1/2. fázis· Idience Co., Ltd.· Forrás
Fut, nem toboroz
MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients
NCT04651634· 2. fázis· MitoImmune Therapeutics· Forrás
Fut, nem toboroz
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
NCT04680052· 3. fázis· Incyte Corporation· Forrás
Fut, nem toboroz
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer
NCT05673772· 2. fázis· Kyungpook National University Hospital· Forrás
Fut, nem toboroz
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
NCT04404283· 3. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás
Fut, nem toboroz
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599· 1/2. fázis· Genmab· Forrás